CONGRESS, GRAPPLING WITH Contaminated CHINESE DRUGS, IS Obstructed BY LACK OF FDA Omission IN U.S. PHARMACEUTICAL SUPPLY CHAIN

Following significant reviews of Chinese-produced prescriptions that contained cancer-causing fixings, Congress is seriously investigating the U.S. store network of nonexclusive medications. Around 80 percent of producers that make key elements for the household medication market is situated outside the United States, as indicated by the U.S. Nourishment and Drug Administration (FDA). In any case, for certain medications, China is the main pro....